Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

SoftBank Attempt To Get Downsized $6 Billion OpenAi Margin Loan Stalls

% of readers think this story is Fact. Add your two cents.


SoftBank Attempt To Get Downsized $6 Billion OpenAi Margin Loan Stalls

One month ago, Japanese tech giant SoftBank Group, was forced to downsize plans for a $10 billion margin loan backed by its OpenAI stake after facing hesitation from some creditors. Today, it couldn’t even get that done after talks with potential creditors to raise the downsized $6 billion stalled amid rising concerns about the collateral value, Bloomberg reported citing people familiar with the matter. 

As a result, the company is now considering various different fundraising options, although it could still move forward with the margin loan at a later stage, they added.

It’s unclear why the margin loan discussions stalled. SoftBank had allegedly secured some $5 billion for the loan before the development, although it was unclear if those were verbal or written commitments. Judging by the outcome, the commitments were tenuous at bet. 

According to the report, the current inaction on the margin loan comes even after some of the potential lenders who had been pitched on it – and who did not view it in an all too favorable light to start – said that they’d started to consider it in a more favorable light, after news last month that the ChatGPT creator was preparing to file for an initial public offering.

Previously some of the potential creditors pitched on the margin loan had expressed concerns about the difficulty of reaching a valuation for an unlisted company like OpenAI. As noted above, SoftBank downsized the loan’s initial target size by 40% after facing pushback from some of the potential lenders. 

“The margin loan is just one piece of a much larger puzzle, and unless we see a clear deterioration in their ability to raise funds this way, we don’t view it as a standalone red flag,” said Hua Cheng, head of Asia credit research at AllianceBernstein. “The best‑case scenario is an OpenAI IPO this year, with SoftBank offloading part of its stake to pay down debt. That would be consistent with what credit investors want.”

OpenAI filed confidentially for an IPO in the US, joining artificial intelligence rivals in tapping public markets to fund ambitious growth plans. The firm is working with Goldman  and Morgan Stanley on a potential listing as soon as in the fall. 

Loan aside, markets have witnessed a broader debate in recent months about SoftBank’s commitments of more than $60 billion to OpenAI at a time when recent breakthroughs by resurgent rival Anthropic PBC have raised doubts for some investors about the business. Within SoftBank itself, some officials had grown anxious about that commitment, according to Bloomberg.

Never one to back down, Masa Son – who nearly went broke after the dot com bubble burst – has been ramping up its broader AI plans. Late last month, it said that SoftBank plans to invest as much as €75 billion – which it does not have - to build artificial intelligence data center capacity in France, saying the country is poised to become a top European hub for AI infrastructure (narrator: it’s not). 

But storm clouds are gathering again for Masa: looming in the background is a $40 billion bridge financing that supported the conglomerate’s investments in OpenAI, and which SoftBank must repay in March 2027. SoftBank has said that borrowing would likely be repaid “through the utilization of existing assets and other financing measures.”

While SoftBank has a number of potential fundraising options, it’s unclear if it would opt to use any of them. Those include potential issuance of more bonds, or possibly borrowing against other listed holdings in its portfolio, although if it can’t get a margin loan against its portfolio crown jewel, one wonders what terms its other assets would garner. Its stakes include ones in Arm Holdings and Intel, whose shares have jumped 197% and 192%, respectively, so far this year amid the AI boom. 

Following the news, Softbank shares tumbled as much as 9.7% Wednesday. Even after declines, SoftBank’s stock was still up about 45% for the period, extending gains in recent weeks after the company reported a jump in quarterly profit due largely to valuation gains on its OpenAI investment. On June 1, SoftBank overtook Toyota Motor Corp. as Japan’s most valuable company by market capitalization. 

Tyler Durden Wed, 06/10/2026 – 21:31


Source: https://freedombunker.com/2026/06/10/softbank-attempt-to-get-downsized-6-billion-openai-margin-loan-stalls/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login